Banks To Shop $1B TLB For King Pharm

By Richard Kellerhals

September 29, 2008

Credit Suisse and Wachovia are hoping to inject some life into the leveraged loan market with a new $1 billion term loan B for King Pharmaceuticals...

The full article is available to Leveraged Finance News subscribers only

SUBSCRIBE NOW!
$1275 for 1 Year(48 issues in all) and Save 20%
Free Trial
Sign up for Leveraged Finance News's 3-Week Free Trial

Already a print subscriber? As a print subscriber, you are entitled to online access. Please click here to activate your account.

Related Items